$60.08
0.520.87%
At close: -
$61.59
1.512.52%
After Hours: Feb 28, 4:05 PM EDT
Virtus LifeSci Biotech Products ETF (ARCA: BBP)
Ticker | Name | Share % | |
---|---|---|---|
ADMA | Adma Biologics Inc Com | 4.54% | |
INSM | Insmed Inc | 3.66% | |
TARS | Tarsus Pharmaceuticals Inc | 3.31% | |
MRNA | Moderna therapeutics | 3.19% | |
DCPH | Deciphera Pharmaceuticals Inc | 3.10% | |
AGIO | Agios Pharmaceuticals Inc | 3.01% | |
SRPT | Sarepta Therapeutics Inc | 2.64% | |
PTCT | Ptc Therapeutics Inc | 2.53% | |
LXRX | Lexicon Pharmaceutcl | 2.51% | |
BPMC | Blueprintmedicines Corp. | 2.42% |
The BBP ETF is currently trading at $61.59, which represents a 3.41% change. Over the past 52 weeks, the ETF has traded as high as $69.12 and as low as $50.43.
The expense ratio of BBP is 0.79%. This represents the annual fee that all funds or ETFs charge their shareholders.
The total Assets Under Management (AUM) for BBP is 21.41M. This represents the total market value of the assets managed by the ETF.
BBP follows a Mid Cap Growth investment style.
The top holdings of BBP include: ADMA (4.54%), INSM (3.66%), TARS (3.31%), MRNA (3.19%), DCPH (3.1%). These represent the largest positions in the ETF's portfolio.
Average daily volume data for BBP is currently not available.